MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE

Magnetic Resonance in Medicine

Volumn 50, Issue 2, 2003, Pages 309-314

  Rausch, Martin ^a   Hiestand, P ^a   Baumann, D ^a   Cannet, C ^a   Rudin, M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; IRON OXIDES; MAGNETIZATION;

BLOOD-BRAIN BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNO-HISTOLOGICAL STAINING; INFLAMMATORY PROCESS; MAGNETIZATION TRANSFER IMAGING (MTI); MAGNETIZATION TRANSFER RATIO; MULTIPLE SCLEROSIS; TISSUE DAMAGE;

MAGNETIC RESONANCE IMAGING;

MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BLOOD BRAIN BARRIER; CELL LABELING; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GUINEA PIG; IMMUNIZATION; IMMUNOHISTOLOGY; IN VIVO STUDY; MACROPHAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; RELAPSE; STAINING; TISSUE INJURY;

EID: 0042092062     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10541     Document Type: Article

References (20)

1. Raine CS, Traugott U. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis, Ann NY Acad Sci 1984;436:33-51.
2. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999;24:511-514.
3. Hemmer B, Cepok S, Nessler S, Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 2002;15:227-231.
4. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.
5. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000;192:1075-1080.
6. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669.
7. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
8. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121(Pt 1):3-24.
9. Barkhof F, van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Phil Trans R Soc Lond B Biol Sci 1999;354:1675-1686.
10. Clark JF, Harris GI, Dillon PF. Multisite saturation transfer using DANTE and continuous wave. Magn Reson Med 1991;17:274-278.
11. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, Lavi E, Cohen JA. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.
12. Rausch M, Baumann D, Neubacher U, Rudin M. In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 2002;15:278-283.
13. Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudibre E, Brochet B, Canioni P, Caille JM. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999;41:329-333.
14. Rausch M, Sauter A, Froehlich J, Neubacher U, Radü EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 2001;46:1018-1022.
15. Swanson LW. Brain maps. Amsterdam: Elsevier; 1998.
16. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM. Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA 1999;8:185-189.
17. Bulte JW, de Jonge MW, de Leij L, The TH, Kamman RL, Blaauw B, Zuiderveen F, Go KG. Passage of DMP across a disrupted BBB in the context of antibody- mediated MR imaging of brain metastases. Acta Neurochir Suppl (Wien) 1990;51:43-45.
18. Muldoon LL, Pagel MA, Kroll RA, Roman-Goldstein S, Jones RS, Neuwelt EA. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery. Am J Neuroradiol 1999;20:217-222.
19. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Rev 2001;36:258-264.
20. Ransohoff RM. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 1999;98:57-68.